Commercial strain-derived clinical Saccharomyces cerevisiae can evolve new phenotypes without higher pathogenicity.
Walter P PflieglerEnikő BorosKitti PázmándiÁgnes JakabImre ZsugaRenátó KovácsEdit UrbánZsuzsa AntunovicsAttila BácsiMatthias SipiczkiLászló MajorosIstván PócsiPublished in: Molecular nutrition & food research (2017)
Isolates in this study offer an interesting insight into the potential microevolution of probiotic and food strains in human hosts. These commensal yeasts display various changes in their phenotypes, indicating that the colonization of the host does not necessarily impose a selective pressure toward higher virulence/pathogenicity.